-
Product Insights
NewHypothyroidism – Drugs In Development, 2024
Empower your strategies with our Hypothyroidism – Drugs In Development, 2024 report and make more profitable business decisions. Hypothyroidism (underactive thyroid) is a condition in which the thyroid gland doesn't produce enough of certain important hormones. Signs and symptoms include fatigue, constipation, dry skin, puffy face, muscle weakness, muscle aches, tenderness and stiffness, pain, and stiffness. Risk factors include autoimmune diseases, thyroid surgery, radiation therapy, and family history of thyroid disease. The Hypothyroidism drugs in development market research report provide comprehensive...
-
Product Insights
NewThyroid Gland Disorders – Drugs In Development, 2024
Empower your strategies with our Thyroid Gland Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Thyroid gland disorders are conditions that affect the function of the thyroid, a butterfly-shaped gland in the front of the neck. The thyroid produces hormones that regulate metabolism, growth, development and body temperature. Some of the common thyroid disorders are hypothyroidism, goiter, hyperthyroidism, and thyroid cancer. Thyroid disorders can be diagnosed by blood tests that measure the levels of thyroid hormones...
-
Company Profile
Synthon International Holdings BV – Company Profile
Synthon International Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture, and distribution of generics, active pharmaceutical ingredients and biopharmaceutical products. It provides small molecule generic products in the therapeutic areas of allergy, anti-infective, cardiovascular, central nervous system, oncology, skeletal and urology. It’s products are approved by regulatory agencies in over 90 countries. It operates research and development facilities and manufacturing facilities to carry out...
Add to Basket -
Product Insights
Hypothyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hypothyroidism (underactive thyroid) is a condition in which thyroid gland doesn't produce enough of certain important hormones. Signs and symptom include fatigue, constipation, dry skin, puffy face, muscle weakness, muscle aches, tenderness and stiffness, pain and stiffness. Risk factors include autoimmune diseases, thyroid surgery, radiation therapy and family history of thyroid disease. The Hypothyroidism pipeline drugs market research report provides a comprehensive information on the therapeutics under development for Hypothyroidism, complete with analysis by stage of development, drug target, mechanism...
-
Product Insights
Parkinson’s Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of dopaminergic neurons in substantia nigra. Symptoms generally develop slowly over years. People with PD experience dyskinesia, dystonia, tremor, stiffness and impaired locomotory functions. Risk factors include age, genetic factors, environmental factors and gender. Treatment options include anticholinergics, COMT inhibitors and dopamine agonists. The Parkinson’s disease pipeline drugs market research report provides comprehensive information on the therapeutics under...
-
Product Insights
Phobia Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Phobia Global Clinical Trials Review, H1, 2018" provides an overview of Phobia clinical trials scenario. This report provides top line data relating to the clinical trials on Phobia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Fungemia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Fungemia Global Clinical Trials Review, H2, 2017" provides an overview of Fungemia clinical trials scenario. This report provides top line data relating to the clinical trials on Fungemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Cryptococcal Meningitis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2017" provides an overview of Cryptococcal Meningitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptococcal Meningitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cryptococcosis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Cryptococcosis Global Clinical Trials Review, H2, 2017" provides an overview of Cryptococcosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptococcosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hormone Sensitive Breast Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Hormone Sensitive Breast Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Hormone Sensitive Breast Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...